Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model
Pakistan Journal of Pharmaceutical Sciences · 09.11.2026
DOI: 10.36721/pjps/2026.40.16885.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Pharmaceutical Sciences, online erschienen am 09.11.2026. Verfasst von Lu Liu. Die Arbeit nennt 24 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis-induced cardiomyopathy (SICM), a significant cardiovascular complication of sepsis, necessitates prompt and effective management. While timely antimicrobial treatment forms the bedrock of early sepsis management, the relationship between the timing of piperacillin/tazobactam administration and the development of SICM remains incompletely characterized.
Objectives
The primary objective of this study was to investigate the association between early piperacillin/tazobactam administration and SICM incidence and short-term outcomes. A secondary objective was to identify factors associated with SICM and to develop an exploratory model for its prediction.
Methods
This single-center, retrospective observational study included 149 adults with sepsis admitted between January 2023 and January 2026. Patients were categorized into two groups: Early treatment (≤1 h; n=68) or delayed treatment (>1 h; n=81). SICM was assessed using echocardiographic criteria. Clinical outcomes were compared using univariate and multivariable logistic regression. Internal validation was performed using 1,000 bootstrap resamples.
Results
SICM occurred in 15/68 (22.06%) early-treatment patients and 33/81 (40.74%) delayed-treatment patients (P=0.014). Twenty-eight-day mortality was 14.71% versus 29.63% (P=0.029) and ICU and total hospital stays were shorter in the early-treatment group (both P
Zitieren
APA
Liu, L. (2026). Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model. Pakistan Journal of Pharmaceutical Sciences. https://doi.org/10.36721/pjps/2026.40.16885.1
Vancouver
Liu L. Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model. Pakistan Journal of Pharmaceutical Sciences. 2026. doi:10.36721/pjps/2026.40.16885.1
BibTeX
@article{Liu2026,
author = {Liu, Lu},
title = {Early piperacillin/tazobactam administration and sepsis-induced cardiomyopathy in emergency department patients: An observational study and exploratory prediction model},
journal = {Pakistan Journal of Pharmaceutical Sciences},
year = {2026},
doi = {10.36721/pjps/2026.40.16885.1}
}
EUVIMED